Hong Kong Pharma Digital Technology Holdings Limited (HKPD) Stock
Hong Kong Pharma Digital Technology stock price chart
HKPD stock quote & key statistics
Hong Kong Pharma Digital Technology annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2026 | $13.4M | -$1.1M | — |
| FY2025 | $20.3M | -$27,056 | — |
| FY2024 | $16.7M | $1.3M | — |
| FY2023 | $12.6M | $998,196 | — |
Fiscal year ending March 31. Source: company filings via EODHD.
About Hong Kong Pharma Digital Technology Holdings Limited
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products.
The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Hong Kong Pharma Digital Technology stock FAQ
What is the Hong Kong Pharma Digital Technology stock ticker symbol?
Hong Kong Pharma Digital Technology Holdings Limited trades on the NASDAQ under the ticker symbol HKPD.
What sector and industry is Hong Kong Pharma Digital Technology in?
Hong Kong Pharma Digital Technology Holdings Limited is classified in the Healthcare sector, Medical Distribution industry.
How many employees does Hong Kong Pharma Digital Technology have?
Hong Kong Pharma Digital Technology Holdings Limited has about 11 full-time employees.
What were Hong Kong Pharma Digital Technology's revenue and earnings last fiscal year?
Hong Kong Pharma Digital Technology reported revenue of $13.4M and net income of -$1.1M in fiscal 2026. Revenue declined 33.9% from the prior year.
When did Hong Kong Pharma Digital Technology go public?
Hong Kong Pharma Digital Technology stock began trading on January 15, 2025.